Multi-Drug Resistant Organism Network (MDRO Network)
Multi-Drug Resistant Organism Network - MDRO Network
Sponsor: Duke University
This observational or N/A phase trial investigates Bacterial Infections and Infections Resistant to Multiple Drugs and is currently completed. Duke University leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2023 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Apr 2023 [monthly]
Completed
▶ Show 8 earlier versions
-
Jun 2021 — Dec 2021 [monthly]
Completed
-
Jan 2021 — Jun 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Oct 2020 — Nov 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2020 — Oct 2020 [monthly]
Active Not Recruiting
-
Jan 2020 — Jun 2020 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Sep 2019 — Jan 2020 [monthly]
Enrolling By Invitation
-
Sep 2018 — Sep 2019 [monthly]
Enrolling By Invitation
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .